Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


4th World Epigenetics Summit

04 Dec 2012 - 06 Dec 2012 - London, UK



Bookmark and Share


The 4th World Epigenetics Summit provides a unique platform on which senior representatives from GSK, Constellation and Epizyme share ideas with leading academic figures such as Tony Kouzarides and Chas Bountra. In bringing together the minds behind the most exciting drugs in development, the meeting represents two days dedicated to overcoming the most pressing challenges in epigenetic drug development.

Why attend?

Get an up-to-the-minute snapshot of the very latest epigenetic target classes for disease therapy from Epizyme, GSK and Constellation Pharmaceuticals

 Learn how the SGC are driving innovation by open source chemical probe design

 Discover the excitement that epigenetic drugs are generating in the clinic with 4SC

 Explore the potential of epigenetic modulation in non-oncological disease indications with GSK

Get excited at the potential of RNA therapeutics in a range of disease indications with RaNA Therapeutics

Find out how to optimize methods, assays and practices throughout the production pipeline so you can maximize the value of your R&D spend




Further information
Scientific News
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Validating the Accuracy of CRISPR-Cas9
IBS Researchers create multiplex Digenome-seq to find errors in CRISPR-Cas9 processes.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
How to Unlock Inaccessible Genes
An international team of biologists has discovered how specialized enzymes remodel the extremely condensed genetic material in the nucleus of cells in order to control which genes can be used.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!